|
Vaccine Detail
Marburg virus DNA prime/boost vaccine DNA/rAd5-GP encoding GP from strain Angola |
Vaccine Information |
- Vaccine Name: Marburg virus DNA prime/boost vaccine DNA/rAd5-GP encoding GP from strain Angola
- Target Pathogen: Marburg Virus
- Target Disease: Hemorrhagic fever
- Vaccine Ontology ID: VO_0004389
- Type: DNA vaccine
- Status: Research
- Host Species as Laboratory Animal Model: Macaque
- GP from Musoke Marburgvirus
gene engineering:
- Type: DNA vaccine construction
- Description: Vector rAd type 5 (rAd5) expressed GP of MARV (Geisbert et al., 2010).
- Detailed Gene Information: Click Here.
- DNA vaccine plasmid:
- DNA vaccine plasmid name:
- DNA vaccine plasmid VO ID: VO_0005004
- Immunization Route: Intramuscular injection (i.m.)
|
Host Response |
Macaque Response
- Vaccine Immune Response Type: VO_0000286
- Immune Response: The vaccine induced humoral responses , as well as CD4(+) and CD8(+) cellular immune responses, with skewing toward CD4(+) T-cell activity against MARV GP. The highest antibody titers were achieved with a heterologous prime-boost vaccine. rAd5-GP boosted titers in DNA-primed animals more than 2 orders of magnitude to a final prechallenge GP ELISA IgG titer of 1:237,167 (Geisbert et al., 2010).
- Efficacy: Heterologous prime-boost with DNA/rAd vectors generated protective immunity in all subjects after challenge with a lethal dose of MARV Angola (Geisbert et al., 2010).
|
References |
Geisbert et al., 2010: Geisbert TW, Bailey M, Geisbert JB, Asiedu C, Roederer M, Grazia-Pau M, Custers J, Jahrling P, Goudsmit J, Koup R, Sullivan NJ. Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates. Journal of virology. 2010; 84(19); 10386-10394. [PubMed: 20660192].
|
|